| Income Statement |
| Total Revenue | 1.95B |
|
| Revenues (USD) | 1.95B |
| Cost of Revenue | 914.63M |
| Gross Profit | 1.03B |
| Operating Expenses | 301.04M |
| Research and Development Expense | 792.00K |
| Selling, General and Administrative Expense | 125.89M |
| Operating Income | 729.45M |
| Interest Expense | 36.96M |
| Income Tax Expense | 145.51M |
| Net Income | 535.22M |
| Net Income Common Stock | 535.22M |
| Net Income Common Stock (USD) | 535.22M |
| Consolidated Income | 548.21M |
| Net Income to Non-Controlling Interests | 13.00M |
| Earnings per Basic Share | 1.73 |
| Earnings per Basic Share (USD) | 1.73 |
| Earnings per Diluted Share | 1.72 |
| Earning Before Interest & Taxes (EBIT) | 717.69M |
| Earning Before Interest & Taxes (USD) | 717.69M |
| Weighted Average Shares | 308.93M |
| Weighted Average Shares Diluted | 311.43M |
| Balance Sheet |
| Investments | 253.16M |
| Investments Non-Current | 253.16M |
| Trade and Non-Trade Receivables | 486.65M |
| Current Assets | 677.93M |
| Property, Plant & Equipment Net | 14.30B |
| Total Assets | 15.35B |
| Debt Current | 536.30M |
| Total Debt | 4.75B |
| Current Liabilities | 1.69B |
| Debt Non-Current | 4.21B |
| Total Liabilities | 7.13B |
| Accumulated Retained Earnings (Deficit) | 2.22B |
| Shareholders Equity | 8.06B |
| Shareholders Equity (USD) | 8.06B |
| Assets Non-Current | 14.67B |
| Total Debt (USD) | 4.75B |
| Deferred Revenue | 29.65M |
| Liabilities Non-Current | 5.43B |
| Trade and Non-Trade Payables | 737.98M |
| Tax Liabilities | 1.14B |
| Cash Flow |
| Depreciation, Amortization & Accretion | 207.30M |
| Net Cash Flow from Financing | 1.21B |
| Net Cash Flow / Change in Cash & Cash Equivalents | -210.00M |
| Capital Expenditure | -213.73M |
| Net Cash Flow - Business Acquisitions and Disposals | -2.79B |
| Issuance (Repayment) of Debt Securities | 1.27B |
| Net Cash Flow from Investing | -2.28B |
| Net Cash Flow from Operations | 859.06M |
| Share Based Compensation | 11.73M |